Brief: Interpace Diagnostics Reports Q4 Loss/Share $0.14

Interpace Biosciences

19/03/2019 21:51

March 19 (Reuters) - Interpace Diagnostics Group Inc
 IDXG.O :
    * INTERPACE DIAGNOSTICS GROUP REPORTS FULL YEAR AND FOURTH
QUARTER
2018 FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.14
    * Q4 REVENUE $5.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$5.8
MILLION
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.08 -- REFINITIV IBES
DATA
    * CASH & CASH EQUIVALENTS OF $6.1 MILLION AS OF DECEMBER 31,
2018

Source text for Eikon:  ID:nGNX6YxK6F 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))